Lipocine

airplane divert change block no reject direction oath

Pharma

Lipocine seeks partner for NASH asset in pivot to oral CNS drugs

The biotech will focus on the oral delivery of neuroactive steroids to treat conditions including postpartum depression.

Nick Paul Taylor Sep 26, 2022 10:50am

Antares, Lipocine win FDA nod for oral testosterone med

Mar 29, 2022 11:42am